Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

September 24, 2022

Study Completion Date

September 24, 2022

Conditions
Non-small Cell Lung Cancer
Trial Locations (11)

110063

Action Cancer Hospital, Delhi, Delhi

110085

Rajiv Gandhi Cancer Institute and Research Centre, New Delhi

388001

Zydus Hospitals and Healthcare Research Pvt. Ltd, Anand

500033

Apollo Health City Hospital, Hyderabad

500082

Yashoda Hospitals, Hyderabad

560017

Manipal Hospitals, Bengaluru

560027

HCG Hospital, Bengaluru

560099

Narayana Hrudyalaya, Bangalore

600026

SRM Institute of Medical Science, Vadapalani

700026

Chittaranjan National Cancer Institute, Kolkata

751007

Sparsh Hospitals and Critical Care, Bhubaneshwar

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY